New findings raise questions about the role of ANAs in SLE
Receiving a TNF inhibitor for any indications cut patients’ overall mortality rate by more than one-third. Also today, HHS secretary, Alex Azar blames pharmacy benefit managers for no drop in prescription prices, a DEA ruling may have stoked illicit opioid sales, and taking a bisphosphonate holiday that lasts 2 years or longer is linked with increased risk for fracture.
Listen to the MDedge Daily News podcast for all the details on today’s top news.
We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.